Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Volumetric changes in subcortical structures following repeated ketamine treatment in patients with major depressive disorder: a longitudinal analysis
Yanling Zhou, Fengchun Wu, Weijian Liu, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders
Shalini Dogra, P. Jeffrey Conn
Neuropharmacology (2021) Vol. 196, pp. 108687-108687
Open Access | Times Cited: 50
Hippocampal subfield alterations in schizophrenia and major depressive disorder: a systematic review and network meta-analysis of anatomic MRI studies
Yuan Sun, Na Hu, Mingqi Wang, et al.
Journal of Psychiatry and Neuroscience (2023) Vol. 48, Iss. 1, pp. E34-E49
Open Access | Times Cited: 18
Neurobiology of the Rapid-Acting Antidepressant Effects of Ketamine: Impact and Opportunities
Ryota Shinohara, George K. Aghajanian, Chadi G. Abdallah
Biological Psychiatry (2020) Vol. 90, Iss. 2, pp. 85-95
Closed Access | Times Cited: 44
Neuroplasticity and Psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models
Claudio Agnorelli, Meg J. Spriggs, Kate Godfrey, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 172, pp. 106132-106132
Open Access
How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
Hewa Artin, Sidney Zisook, Dhakshin Ramanathan
World Journal of Psychiatry (2021) Vol. 11, Iss. 6, pp. 201-214
Open Access | Times Cited: 28
miR-9-5p is involved in the rescue of stress-dependent dendritic shortening of hippocampal pyramidal neurons induced by acute antidepressant treatment with ketamine
Jessica Mingardi, Luca La Via, Paolo Tornese, et al.
Neurobiology of Stress (2021) Vol. 15, pp. 100381-100381
Open Access | Times Cited: 28
An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
Sherry-Anne Muscat, Glenn Hartelius, Courtenay Crouch, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 28
The Role of Glutamate Underlying Treatment-resistant Depression
Jeongseop Kim, Tae-Eun Kim, Seung‐Hwan Lee, et al.
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 3, pp. 429-446
Open Access | Times Cited: 12
Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies
Gustavo C. Medeiros, Malcolm Matheson, Isabella Demo, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 10, pp. 790-800
Closed Access | Times Cited: 11
Neuroimaging-Derived Biomarkers of the Antidepressant Effects of Ketamine
Artemis Zavaliangos‐Petropulu, Noor Al‐Sharif, Brandon Taraku, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2022) Vol. 8, Iss. 4, pp. 361-386
Open Access | Times Cited: 17
Functional connectivity between the habenula and default mode network and its association with the antidepressant effect of ketamine
Mingqia Wang, Xiaoyu Chen, Yiru Hu, et al.
Depression and Anxiety (2021) Vol. 39, Iss. 5, pp. 352-362
Open Access | Times Cited: 18
Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation
Jules Mitchell, Daniel F. Hermens, Maxwell R. Bennett, et al.
CNS Drugs (2023) Vol. 37, Iss. 2, pp. 159-180
Open Access | Times Cited: 7
The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality
Yanling Zhou, Chengyu Wang, Xiaofeng Lan, et al.
Journal of Psychiatric Research (2021) Vol. 144, pp. 312-319
Closed Access | Times Cited: 16
Neurostructural Differences in Adolescents With Treatment-Resistant Depression and Treatment Effects of Transcranial Magnetic Stimulation
Bhedita J. Seewoo, Jennifer Rodger, Mark A. Demitrack, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 25, Iss. 8, pp. 619-630
Open Access | Times Cited: 12
Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation
Yanling Zhou, Chengyu Wang, Xiaofeng Lan, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 11
The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial
Haiyan Liu, Xiaofeng Lan, Chengyu Wang, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder
Haiyan Liu, Chengyu Wang, Xiaofeng Lan, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6
Psychosocial factors and hippocampal subfields: The Medea‐7T study
Emma L. Twait, Kim Blom, Huiberdina L. Koek, et al.
Human Brain Mapping (2022) Vol. 44, Iss. 5, pp. 1964-1984
Open Access | Times Cited: 10
A lateralized model of the pain-depression dyad
Anne Margarette S. Maallo, Eric A. Moulton, Christine B. Sieberg, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 876-883
Open Access | Times Cited: 13
Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study
Adam Wojtas, Agnieszka Bysiek, Agnieszka Wawrzczak‐Bargieła, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 100-100
Open Access | Times Cited: 5
Beyond therapeutic potential: a systematic investigation of ketamine misuse in patients with depressive disorders
Keshav Juneja, Sabah Afroze, Zeel Goti, et al.
Discover Mental Health (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Effect of Xiaoyaosan on brain volume and microstructure diffusion changes to exert antidepressant-like effects in mice with chronic social defeat stress
Yongxin Li
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Brain structural changes underlying clinical symptom improvement following fast-acting treatments in treatment resistant depression
Zhiliang Long, Jiao Li, Marco Marino
Journal of Affective Disorders (2024) Vol. 369, pp. 52-60
Closed Access | Times Cited: 1
NLX-101, a highly selective 5-HT1A receptor biased agonist, mediates antidepressant-like activity in rats via prefrontal cortex 5-HT1A receptors
Ronan Depoortère, Agnès L. Auclair, Adrian Newman‐Tancredi
Behavioural Brain Research (2020) Vol. 401, pp. 113082-113082
Closed Access | Times Cited: 12
Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study
Adam Wojtas, Agnieszka Bysiek, Agnieszka Wawrzczak‐Bargieła, et al.
(2023)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top